TGA approves MENVEO® vaccine to help protect babies from two months old from meningococcal disease
First ACWY combination vaccine available for use in infants under 12 months old, most at risk from meningococcal disease
Press releases
These press releases are intended for business journalists and analysts/investors
TGA approves MENVEO® vaccine to help protect babies from two months old from meningococcal disease (1)
First ACWY combination vaccine available for use in infants under 12 months old, most at risk from meningococcal disease
TGA approves MENVEO® vaccine to help protect babies from two months old from meningococcal disease (2)
First ACWY combination vaccine available for use in infants under 12 months old, most at risk from meningococcal disease
Research shows hay fever nothing to sneeze at
Interior design guru Darren Palmer shares his hay fever story
Read more - Research shows hay fever nothing to sneeze at Read more
GSK Hepatitis B vaccine availability
What Aussie parents need to know about meningococcal disease
Read more - What Aussie parents need to know about meningococcal disease Read more
The three letters making Australian men disappear
INTERNATIONAL MEN’S HEALTH WEEK
- Life interrupted for Australian men as 1 in 3 over 50 affected by BPH
- New Prostate Health campaign urges men affected to consult GP
Read more - The three letters making Australian men disappear Read more
Access to Breo Ellipta for respiratory patients on the PBS is unchanged
GSK’s respiratory medicine Breo Ellipta (fluticasone furoate/vilanterol trifenatate 100/25mcg and 200/25mcg) continues to be available to appropriate patients with asthma and COPD on the PBS.
Read more - Access to Breo Ellipta for respiratory patients on the PBS is unchanged Read more
GSK confirms that Bexsero (meningococcal B vaccine) will be available for purchase in Australia next week
GSK transfers Ultiva to Aspen in Australia
Read more - GSK transfers Ultiva to Aspen in Australia Read more
